Superworth

Ensign price to free cash flow ENSG

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026
24.4×
10-year median
25.0×
Against its 10-year history
47th
percentile: 0 is its lowest day, 100 its highest
10-year range
11.3× to 117×
Peer median
19.7×

Ensign's price to free cash flow is 24.4× as of Oct 23, 2026.

That is below its ten-year median of 25.0×, close to the middle of its last ten years.

Over that time it ranged from 11.3× in Oct 2020 to 117× in Oct 2017.

The median for 10 hospital and care facility stocks of a similar size is 19.7×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far24.4×21.5×36.1×
202535.3×31.3×41.6×
202439.8×24.6×45.8×
202326.8×23.2×30.8×
202224.5×17.3×25.2×
202119.9×13.7×19.9×
202014.0×11.3×23.5×
201920.1×14.9×23.5×
201816.8×16.2×89.8×
201783.3×41.2×117×
201649.5×39.9×50.7×
2015213×27.7×248×
201463.7×8.4×67.4×
20139.8×6.3×10.7×
20129.7×9.0×15.7×

Against its peers

Companies in Medical - Care Facilities nearest Ensign's size, closest first, today.

CompanyPrice to free cash flow
ENSGEnsign24.4×
UHSUniversal Health Services13.0×
DVADavita7.3×
BTSGBrightSpring Health Services29.6×
EHCEncompass Health29.6×
PACSPACS16.6×
CHEChemed20.7×
SHCSotera Health45.8×
CONConcentra Group Holdings Parent18.7×
LFSTLifeStance Health28.4×
THCTenet Healthcare7.2×
Peer median19.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Ensign

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.